Fri, November 19, 2021
Thu, November 18, 2021
Wed, November 17, 2021

Thomas Smith Initiated (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021

Thomas Smith of SVB Leerink, Initiated "Viridian Therapeutics, Inc." (VRDN) at Buy and Held Target at $32 on, Nov 18th, 2021.

Thomas has made no other calls on VRDN in the last 4 months.



There are 2 other peers that have a rating on VRDN. Out of the 2 peers that are also analyzing VRDN, 0 agree with Thomas's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Thomas


  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $36 on, Friday, November 5th, 2021
  • Maneka Mirchandaney of "Evercore ISI Group" Initiated at Buy and Held Target at $40 on, Tuesday, October 12th, 2021